Nuvig Therapeutics Inc. — Sponsor Intelligence | 2 EU Trials

Filter these 2 trials by condition, phase, country and more.

2 Registered trials

1 Recruiting

1 Completed trials

7 Countries active

2 Unique IMPs

100% Results reported

Phase II

Oversight events:

1 serious breach 6 temporary halts 1 corrective measure across 1 trial

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

Top indications

2 total

Showing 1–2 of 2 trials